Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH study

被引:21
作者
Gomez, Pablo [1 ]
Ruilope, Luis Miguel
Barrios, Vivencio
Navarro, Jorge
Prieto, Miguel Angel
Gonzalez, Olga
Guerrero, Lucia
Zamorano, Miguel Angel Sanchez
Filozof, Claudia
机构
[1] Hosp SAS, Dept Nephrol, Jerez de la Frontera 11407, Spain
[2] Hosp 12 Octubre, Hypertens Unit, E-28041 Madrid, Spain
[3] Hosp 12 Octubre, Endocrinol Unit, E-28041 Madrid, Spain
[4] Hosp Ramon & Cajal, Dept Cardiol, E-28034 Madrid, Spain
[5] Salvador Pau, Ctr Hlth, Valencia, Spain
[6] Vallobin Concinos Hlth Ctr, Oviedo, Spain
[7] Bristol Myers Squibb Co, Dept Sci, Madrid, Spain
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷
关键词
D O I
10.1681/ASN.2006080914
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Overweight and obesity are associated with increased cardiovascular risk. Some studies have demonstrated that they also can result in renal damage. The aim of this study was to assess the prevalence of renal insufficiency (RI), defined as a GFR < 60 ml/min per 1.73 m(2), in a cohort of 4585 patients who attended primary care with essential hypertension and a body mass index >= 25 kg/m(2). The patients were classified as overweight and obese according to body mass index (25 to 29.9 and >= 30 kg/m(2), respectively). Abdominal obesity was defined as a waist circumference >= 88 and 102 cm in women and men, respectively. Both groups had a high prevalence of metabolic syndrome (Adult Treatment Panel III). The prevalence of RI was high in both the overweight group (22.7%; 95% confidence interval [CI] 20.6 to 24.9) and in the obese group (22.8%; 95% CI 21.0 to 24.7). The presence of diabetes increased the risk for RI (odds ratio 1.83; 95% CI 1.55 to 2.16). The prevalence of RI was greater in patients with abdominal obesity (23 versus 17%; P < 0.001). In the presence of abdominal obesity, cardiovascular risk factors and components of the metabolic syndrome also were more prevalent. The higher risk for RI with abdominal obesity persisted even after adjustment for dyslipidemia, elevated blood glucose levels, and other variables that are associated with RI (adjusted odds ratio 1.40; 95% CI 0.84 to 2.33). It was concluded that patients who have hypertension and visceral obesity and attend primary care present a higher prevalence of metabolic syndrome and RI.
引用
收藏
页码:S194 / S200
页数:7
相关论文
共 30 条
[1]
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study [J].
Ärnlöv, J ;
Evans, JC ;
Meigs, JB ;
Wang, TJ ;
Fox, CS ;
Levy, D ;
Benjamin, EJ ;
D'Agostino, RB ;
Vasan, RS .
CIRCULATION, 2005, 112 (07) :969-975
[3]
Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis [J].
Bonnet, F ;
Deprele, C ;
Sassolas, A ;
Moulin, P ;
Alamartine, E ;
Berthezène, F ;
Berthoux, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :720-727
[4]
Glomerular hemodynamics in severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Korzets, A ;
Ramadan, E ;
Hirsch, J ;
Gafter, U .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) :F817-F822
[5]
Relationship of gender, age, and body mass index to errors in predicted kidney function [J].
Cirillo, M ;
Anastasio, P ;
De Santo, NG .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (09) :1791-1798
[6]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]
PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]
de Francisco ALM, 2005, NEFROLOGIA, V25, P66
[9]
Cardiovascular risk factor profiles and kidney function stage in the US general population: The NHANES III study [J].
Foley, RN ;
Wang, CC ;
Collins, AJ .
MAYO CLINIC PROCEEDINGS, 2005, 80 (10) :1270-1277
[10]
Predictors of new-onset kidney disease in a community-based population [J].
Fox, CS ;
Larson, MG ;
Leip, EP ;
Culleton, B ;
Wilson, PWF ;
Levy, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (07) :844-850